drugset / Trial / NCT00716963

Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

NCT00716963

RandomizedCrossoverDouble-blindBasic science

Summary

The investigators propose a 3-treatment, placebo-controlled, double-dummy, double-blinded, randomized, crossover study in which single doses of placebo, will be compared to Fluticasone propionate (Flovent Diskus) 250 mcg and budesonide 400 mcg administered after allergen challenge, at cessation of the early allergic reaction (at 20% fall in FEV1 from post-allergen peak)

Timeline

Start
2008-07
Primary completion
2008-11
Completion
2008-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 400 ug
Comparator Fluticasone propionate Other / unclassified 250 ug

Indications